Estimating the Period Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During the Omicron (BA.1) Surge in New York City (NYC), 1 January to 16 March 2022-Reference-Cited by-同舟云学术

Estimating the Period Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During the Omicron (BA.1) Surge in New York City (NYC), 1 January to 16 March 2022

Published:2022-08-12 Issue:3 Volume:76 Page:e499-e502
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Qasmieh Saba A¹²^ORCID,Robertson McKaylee M¹²,Teasdale Chloe A¹²^ORCID,Kulkarni Sarah G¹,Nash Denis¹²

Affiliation:

1. Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY) , New York, New York , USA

2. Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY) , New York, New York , USA

Abstract

Abstract In a population-based survey of adults in New York City, we assessed positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (including via exclusive at-home testing) and possible cases among untested respondents. An estimated 27.4% (95% confidence interval [CI]: 22.8%–32.0%) or 1.8 million adults (95% CI: 1.6–2.1 million) had SARS-CoV-2 infection between 1 January and 16 March 2022.

Funder

CUNY Institute for Implementation Science in Population Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac644/45634449/ciac644.pdf

Reference14 articles.

1. Substantial underestimation of SARS-CoV-2 infection in the United States;Wu;Nat Commun,2020

2. Exploring surveillance data biases when estimating the reproduction number: with insights into subpopulation transmission of COVID-19 in England;Sherratt;Philos Trans R Soc Lond B Biol Sci,2021

3. The COVID-19 Self-Testing through Rapid Network Distribution (C-STRAND) trial: a randomized controlled trial to increase COVID-19 testing in underserved populations;Bien-Gund;Contemp Clin Trials,2021